Skip to main content
Clinical Trials/NCT03488914
NCT03488914
Completed
Not Applicable

Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

Hunter College of City University of New York2 sites in 1 country86 target enrollmentJune 15, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use
Sponsor
Hunter College of City University of New York
Enrollment
86
Locations
2
Primary Endpoint
Condomless Anal Sex Acts
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.

Detailed Description

We will conduct a comparative effectiveness trial (CET) with two intensities of treatment to be offered following field-based HIV counseling and testing (C\&T) - the young men's health project (YMHP) intervention and an enhanced "treatment as usual" (eTAU) condition involving HIV prevention services provided at two community based organizations (CBOs) to test their relative effectiveness in reducing substance use and sexual risk behavior among HIV-negative YMSM. In collaboration with two CBOs, our goals are to better understand substance use and sexual health-related outcomes among HIV-negative YMSM who are unlikely to be treatment seeking and to implement the YMHP intervention in a way that will maximize portability and scalability. Working together with our collaborators will help to address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce substance use and HIV infection among YMSM.

Registry
clinicaltrials.gov
Start Date
June 15, 2016
End Date
April 30, 2021
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Hunter College of City University of New York
Responsible Party
Principal Investigator
Principal Investigator

Tyrel Starks

Associate Professor

Hunter College of City University of New York

Eligibility Criteria

Inclusion Criteria

  • HIV-negative test result from the past 90 days
  • 15-29 years of age
  • Born biologically male or currently identifying as male
  • Sex with men in the past 90 days
  • ≥ 5 days of illicit drug use in the past 90 days
  • ≥ 1 episode of condomless anal sex (CAS) in the past 90 days, or a positive sexually transmitted infection test result in the past 90 days.
  • Living in the New York City area
  • Able to communicate in English

Exclusion Criteria

  • Serious cognitive or psychiatric impairments
  • ≥5 days of injection drug use in the past 90 days
  • Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)

Outcomes

Primary Outcomes

Condomless Anal Sex Acts

Time Frame: Baseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of condomless anal sex acts with male partners in the past 90 days

Marijuana Use Days

Time Frame: Baseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of marijuana use days in the past 90 days

Illicit Drug Use Days

Time Frame: Baseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month

The self-reported number of illicit drug use days (not including marijuana) in the past 90 days

Secondary Outcomes

  • Alcohol Use Days(Baseline, 3-Month, 6-Month, 9-Month, 12-Month, 15-Month)

Study Sites (2)

Loading locations...

Similar Trials